Laboratory assay for traumatic brain injury

Active Definitive Contract Awarded Last action

Contract number
W81XWH19C0071
Awardee
Awarding agency
Obligated
$37,550,664

Award facts

Opportunity
Contract value 78% obligated
  • $37,604,628.77 Current, with exercised options
  • $48,418,678.44 Potential, with all options
Completion date 89% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
North Chicago, IL 60064, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00039 -$53,964
Other Administrative Action P00038 $0
Other Administrative Action P00037 $0
Funding Only Action P00036 · Development and food and drug administration approval for traumatic brain injury assay cartridge. $126
Funding Only Action P00035 $907,000
Funding Only Action P00034 · Traumatic brain injury cartridge $235,000
Change Order P00033 -$10,000
Change Order P00032 -$15,324
Change Order P00031 $871,534
Change Order P00030 · Development and food & drug administration approval for traumatic brain injury assay cartridge for the signal transducer and activator of transcription -$290,814
Supplemental Agreement for work within scope P00029 · Traumatic brain injury clinical trials and device $302,977
Funding Only Action P00028 · Development and FDA approval to market for a TBI assay cartridge $335,901
Other Administrative Action P00027 · Development and approval request to the FDA for TBI assay cartridge for the i-stat, using UCH-L1 and gfap protein biomarkers $0
Funding Only Action P00026 · Production of assay cartridge and i-stat devices and provide regulatory support. $450,000
Funding Only Action P00025 · Incremental funding only $60,316
Funding Only Action P00024 $150,194
Funding Only Action P00023 $2,612,424
Funding Only Action P00022 $0
Funding Only Action P00021 $350,000
Funding Only Action P00020 $111,111
Funding Only Action P00019 $250,008
Funding Only Action P00018 · Development of a traumatic brain injury (TBI) diagnostic assay using banyan biomarkers, food and drug administration (FDA) approved i-stat devices, and their… $832,000
Supplemental Agreement for work within scope P00017 $0
Funding Only Action P00016 · Development of TBI assays by abbott laboratories, INC., point of care division (abbott), using banyan biomarkers UCH-L1 and gfap for use on the abbott i-stat… $312,542
Exercise an Option P00015 $150,442
Other Administrative Action P00014 $0
Supplemental Agreement for work within scope P00013 $0
Funding Only Action P00012 $4,035,572
Funding Only Action P00011 $832,376
Supplemental Agreement for work within scope P00010 $0
Funding Only Action P00009 · Development of a traumatic brain injury (TBI) diagnostic assay using banyan biomarkers ubiquitin c-terminal hydrolase (UCH-L1) and glial fibrillary acidic… $1,423,725
Funding Only Action P00008 · Develop a food and drug administration (FDA) approved assay cartridge for use in the i-stat device to adjunctively screen and assess the presence or absence… -$734,344
Funding Only Action P00007 · Development and approval request to the food and drug administration (FDA) for TBI assay cartridge for the i-stat, using UCH-L1 and gfap protein biomarkers. $998,194
Funding Only Action P00006 · Development of a traumatic brain injury (TBI) diagnostic assay using banyan biomarkers ubiquitin c-terminal hydrolase (UCH-L1) and glial fibrillary acidic… $2,906,942
Funding Only Action P00005 · For the development and U.S. Food and drug administration (FDA) approval to market for a TBI assay cartridge for the i-stat, using UCHL1 and gfap protein… $976,049
Funding Only Action P00004 · Development and approval request to the food and drug administration (FDA) for TBI assay cartridge for the i-stat $995,000
Other Administrative Action P00003 $3,955,678
Other Administrative Action P00002 $0
Funding Only Action P00001 · Development of a traumatic brain injury (TBI) diagnostic assay using banyan biomarkers ubiquitin c-terminal hydrolase (UCH-L1) and glial fibrillary acidic… $2,600,000
Original award $12,000,000
Show all 40

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a $48.4 million definitive contract to Abbott Laboratories Inc. for laboratory assay development and Food and Drug Administration approval for a traumatic brain injury cartridge on March 1, 2019, with no set-aside.

Place of performance is North Chicago, Illinois. The originating solicitation, posted June 22, 2018 with a due date of July 9, 2018, sought development and FDA approval for a traumatic brain injury assay cartridge. The contract carries a firm fixed-price structure and an ultimate completion date of September 30, 2027.

Quick answers

Who was awarded contract W81XWH19C0071?

W81XWH19C0071 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on March 1, 2019.

How much is contract W81XWH19C0071 worth?

The government has obligated $37,550,664 on W81XWH19C0071. Its current value, with exercised options, is $37,604,629. Its potential value, with all options, is $48,418,678.

Was contract W81XWH19C0071 competed?

The extent of competition for W81XWH19C0071 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login